FIELD OF THE INVENTION
The present invention relates to a pharmaceutical, dental and/or cosmetic composition comprising purified Enamel Matrix Derivative (EMD) proteins, which is depleted of proteinase inhibitor .alpha.1 antichymotrypsin and/or Fetuin A.
BACKGROUND OF THE INVENTION
Enamel matrix
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase of PCT International Application No. PCT/AU00/00599, filed May 26, 2000, which claims priority to Australian Provisional Patent Application No. PQ 0652, filed May 28, 1999, the disclosures of each of which are